A significant shift is being witnessed in the Healthcare sector across the globe.
Across emerging markets, the healthcare sector is witnessing rapid transformation driven by increased penetration of health insurance, participation of large corporates and high government focus resulting in significant capacity expansion, improved infrastructure and service quality. Several interesting underserved opportunities can be potentially addressed while keeping in mind that the market will continue to be ‘private spending led’ and highly price competitive.
Declining R&D productivity and increasing costs are forcing innovative pharma companies towards global sourcing; a move that opens up a world of immense opportunity for Asian companies who can align their capabilities with the opportunities and develop commercial models that appeal to all stakeholders.